Nihon Kohden (OTCMKTS:NHNKY) Shares Gap Down – Here’s Why

Shares of Nihon Kohden Corporation (OTCMKTS:NHNKY) gapped down before the market opened on Tuesday . The stock had previously closed at $9.4825, but opened at $8.8675. Nihon Kohden shares last traded at $8.8925, with a volume of 1,436 shares changing hands.

Analyst Ratings Changes

Separately, Zacks Research raised Nihon Kohden to a “hold” rating in a research report on Monday, April 27th. One research analyst has rated the stock with a Strong Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat, Nihon Kohden currently has an average rating of “Buy”.

Nihon Kohden Price Performance

The company has a 50-day simple moving average of $9.41 and a two-hundred day simple moving average of $10.39. The stock has a market capitalization of $1.52 billion, a price-to-earnings ratio of 15.03 and a beta of 0.41.

Nihon Kohden (OTCMKTS:NHNKY) last issued its earnings results on Thursday, May 14th. The company reported $0.34 earnings per share for the quarter, topping the consensus estimate of $0.24 by $0.10. The firm had revenue of $453.10 million for the quarter, compared to analyst estimates of $414.40 million. Nihon Kohden had a return on equity of 9.48% and a net margin of 6.08%. Research analysts anticipate that Nihon Kohden Corporation will post 0.61 EPS for the current year.

Nihon Kohden Company Profile

Nihon Kohden Corporation is a Tokyo-based manufacturer of medical electronic equipment, founded in 1951. The company has built a reputation for innovation in patient monitoring and diagnostic systems, developing one of Japan’s earliest electrocardiogram (ECG) machines and pioneering transistor-based oscilloscopes for clinical use. Over the decades, Nihon Kohden has expanded its product portfolio to address a wide range of healthcare needs, from emergency response to intensive care and neurology.

The company’s core offerings include patient monitors, ECG and electroencephalograph (EEG) devices, defibrillators, infusion pumps, and neuromonitoring systems.